Avid Bioservices Inc (CDMO)

[Protector]

swg_trd, yes and PPHM said they would look into what he, the Indian doctor, exactly did. Probably the way he placed the dual catheter. That will make a big difference on what tissue is infected. In the brain that in not unimportant.

And, including those results, about a year later the FDA granted a PIII design for Cotara, which validated the test results. And there are people (at the time) that were alive 12 years after treatment (normally they don't make 6 months with that brain cancer).

But the key points are:
- LOW on collateral damge of healthy tissue
- Single 25H infusion needed only
- Possible for ALL SOLID CANCER's that can be reached
- Low surgery compared to completely opening a patient

And for NON BRAIN application:

- A VALID alternative to DAMAGE TUMOR CELLs so that the debris becomes available for the immune system to see with damaging much healthy cells and hence keeping their debris low. This results in the tumor debris to become relatively way more visible to the immune system.